Inactive Instrument
Prevail Therapeutics Inc. Stock
Stocks
PRVL
US74140Y1010
Biotechnology & Medical Research
| 1 day | -0.09% |
| Manager | Title | Age | Since |
|---|---|---|---|
Emily Minkow
PRN | Corporate Officer/Principal | 43 | 2018-10-31 |
Yong Dai
PRN | Corporate Officer/Principal | 55 | 2019-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/22/21 | Issuer sale | Chief Executive Officer | 388,939 | 1.1357% | ||
| 1/22/21 | Issuer sale | Director | 37,000 | 0.1080% | ||
| 1/22/21 | OrbiMed Advisors Private Equity
| Tender | Company | 13,822,463 | 40.3599% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.09% | +0.39% | - | - | 788M | |
| +3.31% | -3.70% | +61.03% | +103.64% | 71.35B | |
| +2.09% | +2.28% | +49.95% | +91.14% | 64.17B | |
| -1.61% | -0.89% | +6.99% | -7.10% | 28.65B | |
| -0.35% | -5.42% | -6.50% | +471.60% | 27.06B | |
| -2.78% | +4.47% | +52.49% | +14.43% | 27.33B | |
| -1.68% | +0.33% | +36.86% | -17.91% | 20.47B | |
| +1.02% | +6.43% | +269.42% | +420.34% | 19.36B | |
| -0.57% | -4.06% | +10.79% | +515.61% | 15.96B | |
| +0.01% | +4.10% | +47.68% | +155.28% | 14.05B | |
| Average | -0.07% | +4.46% | +58.75% | +194.11% | 32.04B | |
| Weighted average by Cap. | +0.74% | +3.31% | +54.89% | +153.88% |
Employees
-
